focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,862.00
Bid: 4,850.00
Ask: 4,859.00
Change: -21.00 (-0.43%)
Spread: 9.00 (0.186%)
Open: 4,886.00
High: 4,897.00
Low: 4,862.00
Prev. Close: 4,883.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restatement of results for new reporting structure

4 Jun 2021 13:13

RNS Number : 9165A
Croda International PLC
04 June 2021
 

Regulatory News Announcement

4 June 2021

 

Croda International Plc

Restatement of results for new reporting structure

 

Croda International Plc ('Croda' or 'the Group') announced in November 2020 that from 2021 it would amend its reporting structure to report under four sectors - Consumer Care, Life Sciences, Performance Technologies and Industrial Chemicals.

 

In advance of its half year results on 27 July 2021, the Group is publishing restated segmental results for half year 2020 to provide a like-for-like comparator.

 

Consumer Care comprises the Personal Care sector, including Iberchem, a customer previously reported within Life Sciences, and the Home Care business unit from Performance Technologies.

 

The table below sets out the new structure, showing half year 2020 results as previously reported and the results for the same period restated to reflect the new structure. There is no impact from the Group's acquisitions of Avanti and Iberchem as they were both completed in the second half of 2020.

Sales

Adjusted operating profit*

Half year ended 30 June 2020

Reported currency

 

As

reported

£m

Restated

£m

As

reported

£m

Restated

£m

Consumer Care

226.7

251.1

68.9

73.7

Life Sciences

182.9

179.8

59.4

57.8

Performance Technologies

216.3

195.0

32.7

29.5

Industrial Chemicals

47.0

47.0

0.6

0.6

Group

672.9

672.9

161.6

161.6

 

* Adjusted operating profit is stated before exceptional items, acquisition costs and amortisation of intangible assets arising on acquisition.

 

Further information

 

David Bishop, Director of Investor Relations and Corporate Affairs: +44 7823 874428

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAAKLEENFEFA
Date   Source Headline
30th Sep 20152:52 pmRNSDirector/PDMR Shareholding
28th Sep 20154:58 pmRNSHolding(s) in Company
21st Sep 20158:32 amRNSDirectorate Change
17th Sep 20154:20 pmRNSDirector/PDMR Shareholding
11th Sep 20152:02 pmRNSDirector/PDMR Shareholding
10th Sep 20159:01 amRNSTransaction in Own Shares
7th Sep 20159:44 amRNSHolding(s) in Company
2nd Sep 201510:49 amRNSHolding(s) in Company
20th Aug 201510:15 amRNSDirector/PDMR Shareholding
14th Aug 20158:25 amRNSDirector Declaration
11th Aug 201511:49 amRNSDirector/PDMR Shareholding
21st Jul 20157:00 amRNSInterim Results
13th Jul 201512:01 pmRNSDirector/PDMR Shareholding
15th Jun 201510:30 amRNSHolding(s) in Company
11th Jun 201512:17 pmRNSDirector/PDMR Shareholding
8th Jun 201512:02 pmRNSDirector/PDMR Shareholding
4th Jun 201510:19 amRNSDirector/PDMR Shareholding
3rd Jun 201510:26 amRNSDirector/PDMR Shareholding
2nd Jun 20152:18 pmRNSDirector/PDMR Shareholding
1st Jun 20155:03 pmRNSDirector/PDMR Shareholding
12th May 20152:28 pmRNSDirector/PDMR Shareholding
28th Apr 20154:53 pmRNSDirector/PDMR Shareholding
23rd Apr 201511:47 amRNSResult of AGM
22nd Apr 20157:00 amRNS1st Quarter Trading Update
16th Apr 20159:13 amRNSHolding(s) in Company
13th Apr 20153:56 pmRNSDirector/PDMR Shareholding
2nd Apr 201510:37 amRNSDirector Declaration
23rd Mar 20155:30 pmRNSAnnual Financial Report
20th Mar 20152:09 pmRNSDirector/PDMR Shareholding
19th Mar 20153:56 pmRNSDirector/PDMR Shareholding
11th Mar 20153:25 pmRNSDirector/PDMR Shareholding
6th Mar 201512:26 pmRNSDirector/PDMR Shareholding
5th Mar 20157:00 amRNSDirectorate Change
27th Feb 20153:15 pmRNSDirector/PDMR Shareholding
26th Feb 201511:51 amRNSDirector Declaration
24th Feb 20157:00 amRNSFinal Results
11th Feb 20152:36 pmRNSDirector/PDMR Shareholding
22nd Jan 201510:04 amRNSHolding(s) in Company
13th Jan 20153:18 pmRNSDirector/PDMR Shareholding
11th Dec 20145:07 pmRNSDirector/PDMR Shareholding
28th Nov 20142:55 pmRNSDirector/PDMR Shareholding
28th Nov 20147:00 amRNSDirector Declaration
28th Nov 20147:00 amRNSDirectorate Change
21st Nov 201410:09 amRNSDirector/PDMR Shareholding
19th Nov 20149:05 amRNSDirector/PDMR Shareholding
13th Nov 20143:17 pmRNSDirector/PDMR Shareholding
11th Nov 20142:13 pmRNSDirector/PDMR Shareholding
10th Nov 20145:31 pmRNSHolding(s) in Company
7th Nov 20144:07 pmRNSDirector/PDMR Shareholding
7th Nov 20147:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.